These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Commission
File Number
|
|
Exact Name of Registrant as Specified in its Charter,
Address of Principal Executive Offices and Telephone Number
|
|
State or other jurisdiction of
incorporation or organization
|
|
I.R.S. Employer
Identification No.
|
|
001-33072
|
|
Leidos Holdings, Inc.
|
|
Delaware
|
|
20-3562868
|
|
|
|
11951 Freedom Drive, Reston, Virginia 20190
|
|
|
|
|
|
|
|
(571) 526-6000
|
|
|
|
|
|
000-12771
|
|
Leidos, Inc.
|
|
Delaware
|
|
95-3630868
|
|
|
|
11951 Freedom Drive, Reston, Virginia 20190
|
|
|
|
|
|
|
|
(571) 526-6000
|
|
|
|
|
|
Leidos Holdings, Inc.
|
Yes
x
No
o
|
|
Leidos, Inc.
|
Yes
x
No
o
|
|
Leidos Holdings, Inc.
|
Yes
x
No
o
|
|
Leidos, Inc.
|
Yes
x
No
o
|
|
Leidos Holdings, Inc.
|
Large accelerated filer
|
ý
|
Accelerated filer
|
¨
|
Non-accelerated filer
|
¨
|
Smaller reporting company
|
¨
|
|
|
|
|
|
|
|
|
|
|
|
Leidos, Inc.
|
Large accelerated filer
|
¨
|
Accelerated filer
|
¨
|
Non-accelerated filer
|
ý
|
Smaller reporting company
|
¨
|
|
Leidos Holdings, Inc.
|
Yes
o
No
x
|
|
Leidos, Inc.
|
Yes
o
No
x
|
|
Leidos Holdings, Inc.
|
74,767,690 shares of common stock ($.0001 par value per share)
|
|
Leidos, Inc.
|
5,000 shares of common stock ($.01 par value per share) held by Leidos Holdings, Inc.
|
|
|
May 2,
2014 |
|
January 31,
2014 |
||||
|
|
(in millions)
|
||||||
|
ASSETS
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
183
|
|
|
$
|
430
|
|
|
Receivables, net
|
1,098
|
|
|
1,088
|
|
||
|
Inventory, prepaid expenses and other current assets
|
280
|
|
|
256
|
|
||
|
Assets of discontinued operations
|
10
|
|
|
20
|
|
||
|
Total current assets
|
1,571
|
|
|
1,794
|
|
||
|
Property, plant and equipment (less accumulated depreciation and amortization of $356 million and $344 million at May 2, 2014 and January 31, 2014, respectively)
|
480
|
|
|
483
|
|
||
|
Intangible assets, net
|
88
|
|
|
94
|
|
||
|
Goodwill
|
1,704
|
|
|
1,704
|
|
||
|
Deferred income taxes
|
14
|
|
|
15
|
|
||
|
Other assets
|
112
|
|
|
72
|
|
||
|
|
$
|
3,969
|
|
|
$
|
4,162
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable and accrued liabilities
|
$
|
740
|
|
|
$
|
716
|
|
|
Accrued payroll and employee benefits
|
253
|
|
|
286
|
|
||
|
Notes payable and long-term debt, current portion
|
3
|
|
|
2
|
|
||
|
Liabilities of discontinued operations
|
8
|
|
|
5
|
|
||
|
Total current liabilities
|
1,004
|
|
|
1,009
|
|
||
|
Notes payable and long-term debt, net of current portion
|
1,330
|
|
|
1,331
|
|
||
|
Other long-term liabilities
|
230
|
|
|
227
|
|
||
|
Commitments and contingencies (Notes 11 and 12)
|
|
|
|
||||
|
Stockholders’ equity:
|
|
|
|
||||
|
Preferred stock, $.0001 par value, 10 million shares authorized and no shares issued and outstanding at May 2, 2014 and January 31, 2014
|
—
|
|
|
—
|
|
||
|
Common stock, $.0001 par value, 500 million shares authorized, 75 million and 80 million shares issued and outstanding at May 2, 2014 and January 31, 2014, respectively
|
—
|
|
|
—
|
|
||
|
Additional paid-in capital
|
1,411
|
|
|
1,576
|
|
||
|
Retained earnings
|
—
|
|
|
25
|
|
||
|
Accumulated other comprehensive loss
|
(6
|
)
|
|
(6
|
)
|
||
|
Total stockholders’ equity
|
1,405
|
|
|
1,595
|
|
||
|
|
$
|
3,969
|
|
|
$
|
4,162
|
|
|
|
Three Months Ended
|
||||||
|
|
May 2,
2014 |
|
May 3,
2013 |
||||
|
|
(in millions, except per share amounts)
|
||||||
|
Revenues
|
$
|
1,320
|
|
|
$
|
1,597
|
|
|
Costs and expenses:
|
|
|
|
||||
|
Cost of revenues
|
1,147
|
|
|
1,377
|
|
||
|
Selling, general and administrative expenses
|
83
|
|
|
128
|
|
||
|
Intangible asset impairment charges
|
—
|
|
|
2
|
|
||
|
Separation transaction and restructuring expenses
|
1
|
|
|
14
|
|
||
|
Operating income
|
89
|
|
|
76
|
|
||
|
Non-operating income (expense):
|
|
|
|
||||
|
Interest income
|
—
|
|
|
4
|
|
||
|
Interest expense
|
(20
|
)
|
|
(20
|
)
|
||
|
Other income, net
|
2
|
|
|
1
|
|
||
|
Income from continuing operations before income taxes
|
71
|
|
|
61
|
|
||
|
Income tax expense
|
(25
|
)
|
|
(21
|
)
|
||
|
Income from continuing operations
|
46
|
|
|
40
|
|
||
|
Discontinued operations (Note 2):
|
|
|
|
||||
|
(Loss) income from discontinued operations before income taxes
|
(15
|
)
|
|
66
|
|
||
|
Income tax benefit (expense)
|
6
|
|
|
(25
|
)
|
||
|
(Loss) income from discontinued operations
|
(9
|
)
|
|
41
|
|
||
|
Net income
|
$
|
37
|
|
|
$
|
81
|
|
|
Earnings per share (Note 8):
|
|
|
|
||||
|
Basic:
|
|
|
|
||||
|
Income from continuing operations
|
$
|
0.60
|
|
|
$
|
0.43
|
|
|
(Loss) income from discontinued operations
|
(0.12
|
)
|
|
0.49
|
|
||
|
|
$
|
0.48
|
|
|
$
|
0.92
|
|
|
Diluted:
|
|
|
|
||||
|
Income from continuing operations
|
$
|
0.59
|
|
|
$
|
0.43
|
|
|
(Loss) income from discontinued operations
|
(0.12
|
)
|
|
0.49
|
|
||
|
|
$
|
0.47
|
|
|
$
|
0.92
|
|
|
Cash dividends declared per share
|
$
|
0.32
|
|
|
$
|
4.48
|
|
|
|
Three Months Ended
|
||||||
|
|
May 2, 2014
|
|
May 3, 2013
|
||||
|
|
(in millions)
|
||||||
|
Net income
|
$
|
37
|
|
|
$
|
81
|
|
|
Other comprehensive income, net of tax
|
—
|
|
|
—
|
|
||
|
Comprehensive income
|
$
|
37
|
|
|
$
|
81
|
|
|
|
Shares of
common stock |
|
Additional
paid-in capital |
|
Retained
earnings |
|
Accumulated
other comprehensive loss |
|
Total
|
|||||||||
|
|
(in millions, except for share amounts)
|
|||||||||||||||||
|
Balance at January 31, 2014
|
80
|
|
|
$
|
1,576
|
|
|
$
|
25
|
|
|
$
|
(6
|
)
|
|
$
|
1,595
|
|
|
Net income
|
—
|
|
|
—
|
|
|
37
|
|
|
—
|
|
|
37
|
|
||||
|
Other comprehensive income, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Issuances of stock, net of cancellations
|
—
|
|
|
4
|
|
|
—
|
|
|
—
|
|
|
4
|
|
||||
|
Shares repurchased and retired or withheld for tax withholdings on vesting of restricted stock
|
(5
|
)
|
|
(175
|
)
|
|
(37
|
)
|
|
—
|
|
|
(212
|
)
|
||||
|
Dividends of $0.32 per share
|
—
|
|
|
—
|
|
|
(25
|
)
|
|
—
|
|
|
(25
|
)
|
||||
|
Adjustments for income tax benefits from stock-based compensation
|
—
|
|
|
(5
|
)
|
|
—
|
|
|
—
|
|
|
(5
|
)
|
||||
|
Stock-based compensation
|
—
|
|
|
11
|
|
|
—
|
|
|
—
|
|
|
11
|
|
||||
|
Balance at May 2, 2014
|
75
|
|
|
$
|
1,411
|
|
|
$
|
—
|
|
|
$
|
(6
|
)
|
|
$
|
1,405
|
|
|
|
Three Months Ended
|
||||||
|
|
May 2, 2014
|
|
May 3, 2013
|
||||
|
|
(in millions)
|
||||||
|
Cash flows from operations:
|
|
|
|
||||
|
Net income
|
$
|
37
|
|
|
$
|
81
|
|
|
Loss (income) from discontinued operations
|
9
|
|
|
(41
|
)
|
||
|
Adjustments to reconcile net income to net cash provided by operations:
|
|
|
|
|
|||
|
Depreciation and amortization
|
19
|
|
|
26
|
|
||
|
Stock-based compensation
|
11
|
|
|
15
|
|
||
|
Intangible asset impairment charges
|
—
|
|
|
2
|
|
||
|
Restructuring charges, net
|
(1
|
)
|
|
5
|
|
||
|
Net gain on sales and disposals of assets
|
(1
|
)
|
|
(10
|
)
|
||
|
Other
|
(1
|
)
|
|
4
|
|
||
|
Change in assets and liabilities, net of effects of acquisitions and dispositions:
|
|
|
|
|
|
||
|
Receivables
|
(49
|
)
|
|
(163
|
)
|
||
|
Inventory, prepaid expenses and other current assets
|
(37
|
)
|
|
48
|
|
||
|
Deferred income taxes
|
—
|
|
|
(1
|
)
|
||
|
Other assets
|
(3
|
)
|
|
9
|
|
||
|
Accounts payable and accrued liabilities
|
25
|
|
|
(11
|
)
|
||
|
Accrued payroll and employee benefits
|
(32
|
)
|
|
(59
|
)
|
||
|
Income taxes receivable/payable
|
14
|
|
|
(3
|
)
|
||
|
Other long-term liabilities
|
1
|
|
|
(4
|
)
|
||
|
Total cash flows used in operating activities of continuing operations
|
(8
|
)
|
|
(102
|
)
|
||
|
Cash flows from investing activities:
|
|
|
|
|
|
||
|
Expenditures for property, plant and equipment
|
(10
|
)
|
|
(18
|
)
|
||
|
Proceeds from sale of assets
|
—
|
|
|
25
|
|
||
|
Other
|
—
|
|
|
2
|
|
||
|
Total cash flows (used in) provided by investing activities of continuing operations
|
(10
|
)
|
|
9
|
|
||
|
Cash flows from financing activities:
|
|
|
|
|
|
||
|
Sales of stock and exercises of stock options
|
2
|
|
|
4
|
|
||
|
Repurchases of stock
|
(212
|
)
|
|
(16
|
)
|
||
|
Dividend payments
|
(24
|
)
|
|
(41
|
)
|
||
|
Other
|
1
|
|
|
—
|
|
||
|
Total cash flows used in financing activities of continuing operations
|
(233
|
)
|
|
(53
|
)
|
||
|
Decrease in cash and cash equivalents from continuing operations
|
(251
|
)
|
|
(146
|
)
|
||
|
Cash flows from discontinued operations:
|
|
|
|
|
|
||
|
Cash provided by (used in) operating activities of discontinued operations
|
4
|
|
|
(26
|
)
|
||
|
Cash used in investing activities of discontinued operations
|
—
|
|
|
(1
|
)
|
||
|
Increase (decrease) in cash and cash equivalents from discontinued operations
|
4
|
|
|
(27
|
)
|
||
|
Total decrease in cash and cash equivalents
|
(247
|
)
|
|
(173
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
430
|
|
|
735
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
183
|
|
|
$
|
562
|
|
|
|
May 2,
2014 |
|
January 31, 2014
|
||||
|
|
(in millions)
|
||||||
|
ASSETS
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
183
|
|
|
$
|
430
|
|
|
Receivables, net
|
1,098
|
|
|
1,088
|
|
||
|
Inventory, prepaid expenses and other current assets
|
280
|
|
|
256
|
|
||
|
Assets of discontinued operations
|
10
|
|
|
20
|
|
||
|
Total current assets
|
1,571
|
|
|
1,794
|
|
||
|
Property, plant and equipment (less accumulated depreciation and amortization of $356 million and $344 million at May 2, 2014 and January 31, 2014, respectively)
|
480
|
|
|
483
|
|
||
|
Intangible assets, net
|
88
|
|
|
94
|
|
||
|
Goodwill
|
1,704
|
|
|
1,704
|
|
||
|
Deferred income taxes
|
14
|
|
|
15
|
|
||
|
Other assets
|
112
|
|
|
72
|
|
||
|
Note receivable from Leidos Holdings, Inc. (Note 6)
|
1,365
|
|
|
1,137
|
|
||
|
|
$
|
5,334
|
|
|
$
|
5,299
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable and accrued liabilities
|
$
|
740
|
|
|
$
|
716
|
|
|
Accrued payroll and employee benefits
|
253
|
|
|
286
|
|
||
|
Notes payable and long-term debt, current portion
|
3
|
|
|
2
|
|
||
|
Liabilities of discontinued operations
|
8
|
|
|
5
|
|
||
|
Total current liabilities
|
1,004
|
|
|
1,009
|
|
||
|
Notes payable and long-term debt, net of current portion
|
1,330
|
|
|
1,331
|
|
||
|
Other long-term liabilities
|
230
|
|
|
227
|
|
||
|
Commitments and contingencies (Notes 11 and 12)
|
|
|
|
||||
|
Stockholders’ equity:
|
|
|
|
||||
|
Common stock, $.01 par value, 10,000 shares authorized, 5,000 shares issued and outstanding at May 2, 2014 and January 31, 2014
|
—
|
|
|
—
|
|
||
|
Additional paid-in capital
|
207
|
|
|
207
|
|
||
|
Retained earnings
|
2,569
|
|
|
2,531
|
|
||
|
Accumulated other comprehensive loss
|
(6
|
)
|
|
(6
|
)
|
||
|
Total stockholders’ equity
|
2,770
|
|
|
2,732
|
|
||
|
|
$
|
5,334
|
|
|
$
|
5,299
|
|
|
|
Three Months Ended
|
||||||
|
|
May 2,
2014 |
|
May 3,
2013 |
||||
|
|
(in millions)
|
||||||
|
Revenues
|
$
|
1,320
|
|
|
$
|
1,597
|
|
|
Costs and expenses:
|
|
|
|
||||
|
Cost of revenues
|
1,147
|
|
|
1,377
|
|
||
|
Selling, general and administrative expenses
|
83
|
|
|
128
|
|
||
|
Intangible asset impairment charges
|
—
|
|
|
2
|
|
||
|
Separation transaction and restructuring expenses
|
1
|
|
|
14
|
|
||
|
Operating income
|
89
|
|
|
76
|
|
||
|
Non-operating income (expense):
|
|
|
|
||||
|
Interest income
|
2
|
|
|
4
|
|
||
|
Interest expense
|
(20
|
)
|
|
(20
|
)
|
||
|
Other income, net
|
2
|
|
|
1
|
|
||
|
Income from continuing operations before income taxes
|
73
|
|
|
61
|
|
||
|
Income tax expense
|
(26
|
)
|
|
(21
|
)
|
||
|
Income from continuing operations
|
47
|
|
|
40
|
|
||
|
Discontinued operations (Note 2):
|
|
|
|
||||
|
(Loss) income from discontinued operations before income taxes
|
(15
|
)
|
|
66
|
|
||
|
Income tax benefit (expense)
|
6
|
|
|
(25
|
)
|
||
|
(Loss) income from discontinued operations
|
(9
|
)
|
|
41
|
|
||
|
Net income
|
$
|
38
|
|
|
$
|
81
|
|
|
|
Three Months Ended
|
||||||
|
|
May 2, 2014
|
|
May 3, 2013
|
||||
|
|
(in millions)
|
||||||
|
Net income
|
$
|
38
|
|
|
$
|
81
|
|
|
Other comprehensive income, net of tax
|
—
|
|
|
—
|
|
||
|
Comprehensive income
|
$
|
38
|
|
|
$
|
81
|
|
|
|
Shares of
common stock |
|
Additional
paid-in capital |
|
Retained
earnings |
|
Accumulated
other comprehensive loss |
|
Total
|
|||||||||
|
|
(in millions, except for share amounts)
|
|||||||||||||||||
|
Balance at January 31, 2014
|
5,000
|
|
|
$
|
207
|
|
|
$
|
2,531
|
|
|
$
|
(6
|
)
|
|
$
|
2,732
|
|
|
Net income
|
—
|
|
|
—
|
|
|
38
|
|
|
—
|
|
|
38
|
|
||||
|
Other comprehensive income, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Balance at May 2, 2014
|
5,000
|
|
|
$
|
207
|
|
|
$
|
2,569
|
|
|
$
|
(6
|
)
|
|
$
|
2,770
|
|
|
|
Three Months Ended
|
||||||
|
|
May 2, 2014
|
|
May 3, 2013
|
||||
|
|
(in millions)
|
||||||
|
Cash flows from operations:
|
|
|
|
||||
|
Net income
|
$
|
38
|
|
|
$
|
81
|
|
|
Loss (income) from discontinued operations
|
9
|
|
|
(41
|
)
|
||
|
Adjustments to reconcile net income to net cash provided by operations:
|
|
|
|
||||
|
Depreciation and amortization
|
19
|
|
|
26
|
|
||
|
Stock-based compensation
|
11
|
|
|
15
|
|
||
|
Intangible asset impairment charges
|
—
|
|
|
2
|
|
||
|
Restructuring charges, net
|
(1
|
)
|
|
5
|
|
||
|
Net gain on sales and disposals of assets
|
(1
|
)
|
|
(10
|
)
|
||
|
Other
|
(2
|
)
|
|
4
|
|
||
|
Change in assets and liabilities, net of effects of acquisitions and dispositions:
|
|
|
|
||||
|
Receivables
|
(49
|
)
|
|
(163
|
)
|
||
|
Inventory, prepaid expenses and other current assets
|
(37
|
)
|
|
48
|
|
||
|
Deferred income taxes
|
—
|
|
|
(1
|
)
|
||
|
Other assets
|
(3
|
)
|
|
9
|
|
||
|
Accounts payable and accrued liabilities
|
25
|
|
|
(11
|
)
|
||
|
Accrued payroll and employee benefits
|
(32
|
)
|
|
(59
|
)
|
||
|
Income taxes receivable/payable
|
14
|
|
|
(3
|
)
|
||
|
Other long-term liabilities
|
1
|
|
|
(4
|
)
|
||
|
Total cash flows used in operating activities of continuing operations
|
(8
|
)
|
|
(102
|
)
|
||
|
Cash flows from investing activities:
|
|
|
|
||||
|
Proceeds on obligations of Leidos Holdings, Inc.
|
3
|
|
|
—
|
|
||
|
Payments on obligations of Leidos Holdings, Inc.
|
(237
|
)
|
|
—
|
|
||
|
Expenditures for property, plant and equipment
|
(10
|
)
|
|
(18
|
)
|
||
|
Proceeds from sale of assets
|
—
|
|
|
25
|
|
||
|
Other
|
—
|
|
|
2
|
|
||
|
Total cash flows (used in) provided by investing activities of continuing operations
|
(244
|
)
|
|
9
|
|
||
|
Cash flows from financing activities:
|
|
|
|
||||
|
Proceeds on obligations of Leidos Holdings, Inc.
|
—
|
|
|
4
|
|
||
|
Payments on obligations of Leidos Holdings, Inc.
|
—
|
|
|
(57
|
)
|
||
|
Other
|
1
|
|
|
—
|
|
||
|
Total cash flows provided by (used in) financing activities of continuing operations
|
1
|
|
|
(53
|
)
|
||
|
Decrease in cash and cash equivalents from continuing operations
|
(251
|
)
|
|
(146
|
)
|
||
|
Cash flows from discontinued operations:
|
|
|
|
||||
|
Cash provided by (used in) operating activities of discontinued operations
|
4
|
|
|
(26
|
)
|
||
|
Cash used in investing activities of discontinued operations
|
—
|
|
|
(1
|
)
|
||
|
Increase (decrease) in cash and cash equivalents from discontinued operations
|
4
|
|
|
(27
|
)
|
||
|
Total decrease in cash and cash equivalents
|
(247
|
)
|
|
(173
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
430
|
|
|
735
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
183
|
|
|
$
|
562
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
May 2, 2014
|
|
May 3, 2013
|
||||
|
|
(in millions)
|
||||||
|
Strategic advisory services
|
$
|
—
|
|
|
$
|
2
|
|
|
Legal and accounting services
|
—
|
|
|
—
|
|
||
|
Lease termination and facility consolidation expenses
|
1
|
|
|
9
|
|
||
|
Severance costs
|
—
|
|
|
3
|
|
||
|
Separation transaction and restructuring expenses in operating income
|
1
|
|
|
14
|
|
||
|
Less: income tax benefit
|
—
|
|
|
(5
|
)
|
||
|
Separation transaction and restructuring expenses, net of tax
|
$
|
1
|
|
|
$
|
9
|
|
|
|
Severance Costs
|
Lease Termination and Facility Consolidation Expenses
|
Total
|
||||||
|
|
(in millions)
|
||||||||
|
Balance as of January 31, 2014
|
$
|
1
|
|
$
|
20
|
|
$
|
21
|
|
|
Charges
|
—
|
|
1
|
|
1
|
|
|||
|
Cash payments
|
(1
|
)
|
(5
|
)
|
(6
|
)
|
|||
|
Balance as of May 2, 2014
|
$
|
—
|
|
$
|
16
|
|
$
|
16
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
May 2, 2014
|
|
May 3, 2013
|
||||
|
|
(in millions)
|
||||||
|
Vested stock issued as settlement of annual bonus accruals
|
$
|
1
|
|
|
$
|
2
|
|
|
Stock issued in lieu of cash dividends
|
$
|
1
|
|
|
$
|
1
|
|
|
Cash paid for income taxes, net of refunds (including discontinued operations)
|
$
|
5
|
|
|
$
|
2
|
|
|
Dividends payable for declared special cash dividend
|
$
|
—
|
|
|
$
|
357
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|||||
|
|
May 2, 2014
|
May 3, 2013
|
||||
|
|
(in millions)
|
|||||
|
Revenues
|
$
|
14
|
|
$
|
1,106
|
|
|
Costs and expenses:
|
|
|
|
|||
|
Cost of revenues
|
14
|
|
998
|
|
||
|
Selling, general and administrative expenses
|
—
|
|
15
|
|
||
|
Separation transaction and restructuring expenses
|
—
|
|
19
|
|
||
|
Operating income
|
$
|
—
|
|
$
|
74
|
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
May 2, 2014
|
|
|
May 3, 2013
|
|
||
|
|
(in millions)
|
||||||
|
Revenues
|
$
|
4
|
|
|
$
|
4
|
|
|
Costs and expenses:
|
|
|
|
|
|
||
|
Cost of revenues
|
3
|
|
|
3
|
|
||
|
Selling, general and administrative expenses (including impairment charges of $9 million for the three months ended May 2, 2014)
|
13
|
|
|
7
|
|
||
|
Intangible asset impairment charges
|
3
|
|
|
2
|
|
||
|
Separation transaction and restructuring expenses
|
—
|
|
|
—
|
|
||
|
Operating loss
|
$
|
(15
|
)
|
|
$
|
(8
|
)
|
|
|
|
|
|
Forgiveness of accounts receivable (net of $32 million bad debt expense)
|
$
|
105
|
|
|
Contingent consideration
|
6
|
|
|
|
Total purchase consideration
|
$
|
111
|
|
|
Property, plant and equipment
|
$
|
248
|
|
|
Other assets
|
8
|
|
|
|
Notes payable assumed (net of debt discount)
|
(148
|
)
|
|
|
Total identifiable net assets acquired
|
108
|
|
|
|
Intangible assets
|
3
|
|
|
|
Total purchase consideration
|
$
|
111
|
|
|
|
|
|
|
|
May 2, 2014
|
|
January 31, 2014
|
||||||||||||||||||||
|
|
Gross carrying value
|
|
Accumulated amortization
|
|
Net carrying value
|
|
Gross carrying value
|
|
Accumulated amortization
|
|
Net carrying value
|
||||||||||||
|
|
(in millions)
|
||||||||||||||||||||||
|
Finite-lived intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Customer relationships
|
$
|
102
|
|
|
$
|
(58
|
)
|
|
$
|
44
|
|
|
$
|
102
|
|
|
$
|
(54
|
)
|
|
$
|
48
|
|
|
Software and technology
|
65
|
|
|
(38
|
)
|
|
27
|
|
|
65
|
|
|
(36
|
)
|
|
29
|
|
||||||
|
Other
|
4
|
|
|
(1
|
)
|
|
3
|
|
|
4
|
|
|
(1
|
)
|
|
3
|
|
||||||
|
Total finite-lived intangible assets
|
171
|
|
|
(97
|
)
|
|
74
|
|
|
171
|
|
|
(91
|
)
|
|
80
|
|
||||||
|
Indefinite-lived intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
In-process research and development
|
10
|
|
|
—
|
|
|
10
|
|
|
10
|
|
|
—
|
|
|
10
|
|
||||||
|
Trade names
|
4
|
|
|
—
|
|
|
4
|
|
|
4
|
|
|
—
|
|
|
4
|
|
||||||
|
Total indefinite-lived intangible assets
|
14
|
|
|
—
|
|
|
14
|
|
|
14
|
|
|
—
|
|
|
14
|
|
||||||
|
Total intangible assets
|
$
|
185
|
|
|
$
|
(97
|
)
|
|
$
|
88
|
|
|
$
|
185
|
|
|
$
|
(91
|
)
|
|
$
|
94
|
|
|
Fiscal Year Ending January 31
|
|
||
|
|
(in millions)
|
||
|
2015 (remainder of the fiscal year)
|
$
|
16
|
|
|
2016
|
20
|
|
|
|
2017
|
17
|
|
|
|
2018
|
11
|
|
|
|
2019
|
6
|
|
|
|
2020 and thereafter
|
4
|
|
|
|
|
$
|
74
|
|
|
|
|
|
|
|
|
|
|
|
Stated interest rate
|
|
Effective interest rate
|
|
May 2,
2014 |
|
January 31, 2014
|
||||||
|
|
(dollars in millions)
|
||||||||||||
|
Leidos Holdings, Inc. senior unsecured notes:
|
|
|
|
|
|
|
|
||||||
|
$450 million notes, which mature in December 2020
|
4.45
|
%
|
|
4.53
|
%
|
|
$
|
449
|
|
|
$
|
449
|
|
|
$300 million notes, which mature in December 2040
|
5.95
|
%
|
|
6.03
|
%
|
|
300
|
|
|
300
|
|
||
|
Leidos, Inc. senior unsecured notes:
|
|
|
|
|
|
|
|
|
|
||||
|
$250 million notes, which mature in July 2032
|
7.13
|
%
|
|
7.43
|
%
|
|
248
|
|
|
248
|
|
||
|
$300 million notes, which mature in July 2033
|
5.50
|
%
|
|
5.78
|
%
|
|
296
|
|
|
296
|
|
||
|
Capital leases and other notes payable due on various dates through fiscal 2021
|
0%-3.7%
|
|
|
Various
|
|
40
|
|
|
40
|
|
|||
|
Total notes payable and long-term debt
|
|
|
|
|
$
|
1,333
|
|
|
$
|
1,333
|
|
||
|
Less current portion
|
|
|
|
|
3
|
|
|
2
|
|
||||
|
Total notes payable and long-term debt, net of current portion
|
|
|
|
|
$
|
1,330
|
|
|
$
|
1,331
|
|
||
|
Fair value of notes payable and long-term debt
|
|
|
|
|
$
|
1,358
|
|
|
$
|
1,350
|
|
||
|
|
|
|
|
|
May 2,
2014 |
|
January 31,
2014 |
||||
|
|
(in millions)
|
||||||
|
Foreign currency translation adjustments, net of taxes of $(1) million as of May 2, 2014 and January 31, 2014
|
$
|
2
|
|
|
$
|
2
|
|
|
Unrecognized net loss on settled derivative instruments associated with outstanding debt, net of taxes of $3 million as of May 2, 2014 and January 31, 2014
|
(5
|
)
|
|
(5
|
)
|
||
|
Unrecognized net loss on defined benefit plan, net of taxes of $2 million as of May 2, 2014 and January 31, 2014
|
(3
|
)
|
|
(3
|
)
|
||
|
Total accumulated other comprehensive loss, net of taxes of $4 million as of May 2, 2014 and January 31, 2014
|
$
|
(6
|
)
|
|
$
|
(6
|
)
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
May 2, 2014
|
|
May 3, 2013
|
||||
|
|
(in millions)
|
||||||
|
Basic EPS:
|
|
|
|
||||
|
Income from continuing operations, as reported
|
$
|
46
|
|
|
$
|
40
|
|
|
Less: allocation of distributed and undistributed earnings to participating securities
|
—
|
|
|
(4
|
)
|
||
|
Income from continuing operations, for computing
basic EPS
|
$
|
46
|
|
|
$
|
36
|
|
|
Net income, as reported
|
$
|
37
|
|
|
$
|
81
|
|
|
Less: allocation of distributed and undistributed earnings to participating securities
|
—
|
|
|
(4
|
)
|
||
|
Net income, for computing basic EPS
|
$
|
37
|
|
|
$
|
77
|
|
|
Diluted EPS:
|
|
|
|
|
|
||
|
Income from continuing operations, as reported
|
$
|
46
|
|
|
$
|
40
|
|
|
Less: allocation of distributed and undistributed earnings to participating securities
|
—
|
|
|
(4
|
)
|
||
|
Income from continuing operations, for computing
diluted EPS
|
$
|
46
|
|
|
$
|
36
|
|
|
Net income, as reported
|
$
|
37
|
|
|
$
|
81
|
|
|
Less: allocation of distributed and undistributed earnings to participating securities
|
—
|
|
|
(4
|
)
|
||
|
Net income, for computing diluted EPS
|
$
|
37
|
|
|
$
|
77
|
|
|
|
Three Months Ended
|
||||
|
|
May 2, 2014
|
|
May 3, 2013
|
||
|
|
(in millions)
|
||||
|
Basic weighted average number of shares outstanding
|
77
|
|
|
84
|
|
|
Dilutive common share equivalents—stock options and
other stock awards
|
1
|
|
|
—
|
|
|
Diluted weighted average number of shares outstanding
|
78
|
|
|
84
|
|
|
|
Three Months Ended
|
||||
|
|
May 2, 2014
|
|
May 3, 2013
|
||
|
|
(in millions)
|
||||
|
Stock options
|
2
|
|
|
5
|
|
|
Vesting stock awards
|
1
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
May 2, 2014
|
|
|
May 3, 2013
|
|
||
|
|
(in millions)
|
||||||
|
Stock-based compensation expense:
|
|
|
|
||||
|
Stock options
|
$
|
2
|
|
|
$
|
2
|
|
|
Vesting stock awards
|
9
|
|
|
13
|
|
||
|
Total stock-based compensation expense recorded in continuing operations
|
$
|
11
|
|
|
$
|
15
|
|
|
Total stock-based compensation expense recorded in discontinued operations
|
$
|
—
|
|
|
$
|
9
|
|
|
Tax benefits recognized from stock-based compensation
|
$
|
4
|
|
|
$
|
6
|
|
|
|
|
Three Months Ended
|
|
||||||
|
|
|
May 2, 2014
|
|
|
May 3, 2013
|
|
|
||
|
Options Granted (in millions)
|
|
0.5
|
|
|
1.3
|
|
*
|
||
|
Weighted average grant-date fair value
|
|
$
|
6.23
|
|
|
$
|
6.81
|
|
*
|
|
Expected term (in years)
|
|
4.8
|
|
|
5.0
|
|
|
||
|
Expected volatility
|
|
25.1
|
%
|
|
25.0
|
%
|
|
||
|
Risk-free interest rate
|
|
1.6
|
%
|
|
0.8
|
%
|
|
||
|
Dividend yield
|
|
2.8
|
%
|
|
3.9
|
%
|
|
||
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
May 2, 2014
|
|
May 3, 2013
|
||||
|
|
(in millions)
|
||||||
|
Revenues:
|
|
|
|
||||
|
National Security Solutions
|
$
|
944
|
|
|
$
|
1,077
|
|
|
Health and Engineering
|
380
|
|
|
521
|
|
||
|
Corporate and Other
|
(4
|
)
|
|
—
|
|
||
|
Intersegment elimination
|
—
|
|
|
(1
|
)
|
||
|
Total revenues
|
$
|
1,320
|
|
|
$
|
1,597
|
|
|
|
|
|
|
||||
|
Operating income (loss):
|
|
|
|
||||
|
National Security Solutions
|
$
|
77
|
|
|
$
|
71
|
|
|
Health and Engineering
|
25
|
|
|
35
|
|
||
|
Corporate and Other
|
(13
|
)
|
|
(30
|
)
|
||
|
Total operating income
|
$
|
89
|
|
|
$
|
76
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
•
|
Achieving internal, or non-acquisition related, revenue growth through internal collaboration and better leveraging of key differentiators across our company and the deployment of resources and investments into higher growth markets;
|
|
•
|
Increasing the growth of our operating profits through improving the quality of our revenues and contract profitability, continued improvement in our information technology (IT) systems infrastructure and related business processes for greater effectiveness and efficiency across all business functions; and
|
|
•
|
Disciplined deployment of our cash resources and use of our capital structure to enhance shareholder value through internal growth initiatives, stock repurchases, dividends, strategic acquisitions and other uses to achieve our goals.
|
|
•
|
Revenues for the three months ended May 2, 2014 decreased 17% from the corresponding period in the prior year. The revenue contraction for the quarter was due to a decrease in National Security Solutions segment revenues of 12% and a decrease in Health and Engineering segment revenues of 27%.
|
|
•
|
Operating income from continuing operations was $89 million for the three months ended May 2, 2014 up from $76 million for the corresponding period in the prior year. The increase in operating income from continuing operations was primarily due to a $13 million reduction in separation and restructuring expenses.
|
|
•
|
Diluted earnings per share from continuing operations for the three months ended May 2, 2014 was $0.59 as compared to $0.43 in the corresponding period in the prior year, primarily due to the aforementioned operating income from continuing operations increase of $13 million and a decrease in the diluted weighted average number of shares outstanding of 6 million shares, or 7%, primarily due to shares repurchased under our accelerated stock repurchase programs.
|
|
•
|
Cash and cash equivalents decreased $247 million during the three months ended May 2, 2014 primarily due to dividend payments of $24 million on Leidos stock and the repurchase of stock for a purchase price of $212 million primarily due to the accelerated stock repurchase program.
|
|
•
|
Net bookings (as defined in “Key Performance Measures—Bookings and Backlog”) were approximately $857 million for the three months ended May 2, 2014. Total backlog was $8.8 billion at May 2, 2014 and $9.3 billion at January 31, 2014.
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
May 2, 2014
|
|
May 3, 2013
|
||||
|
|
(in millions)
|
||||||
|
Revenues
|
$
|
18
|
|
|
$
|
1,110
|
|
|
Costs and expenses:
|
|
|
|
|
|
||
|
Cost of revenues
|
17
|
|
|
1,001
|
|
||
|
Selling, general and administrative expenses (including impairment charges of $9 million for the three months ended May 2, 2014)
|
13
|
|
|
22
|
|
||
|
Intangible asset impairment charges
|
3
|
|
|
$
|
2
|
|
|
|
Separation transaction and restructuring expenses
|
—
|
|
|
19
|
|
||
|
Operating (loss) income
|
$
|
(15
|
)
|
|
$
|
66
|
|
|
|
|
|
|
|
|
|
|
•
|
Funded Backlog.
Funded backlog for contracts with government agencies primarily represents contracts for which funding is appropriated less revenues previously recognized on these contracts, and does not include the unfunded portion of contracts where funding is incrementally appropriated or authorized on a quarterly or annual basis by the U.S. Government and other customers, even though the contract may call for performance over a number of years. Funded backlog for contracts with non-government agencies and commercial customers represents the estimated value on contracts, which may cover multiple future years, under which we are obligated to perform, less revenues previously recognized on these contracts.
|
|
•
|
Negotiated Unfunded Backlog.
Negotiated unfunded backlog represents estimated amounts of revenues to be earned in the future from (1) negotiated contracts for which funding has not been appropriated or otherwise authorized and (2) unexercised priced contract options. Negotiated unfunded backlog does not include future potential task orders expected to be awarded under IDIQ, GSA Schedule, or other master agreement contract vehicles.
|
|
|
May 2,
2014 |
|
January 31,
2014 |
||||
|
|
(in millions)
|
||||||
|
National Security Solutions:
|
|
|
|
||||
|
Funded backlog
|
$
|
1,986
|
|
|
$
|
1,854
|
|
|
Negotiated unfunded backlog
|
5,005
|
|
|
5,604
|
|
||
|
Total National Security Solutions backlog
|
$
|
6,991
|
|
|
$
|
7,458
|
|
|
Health and Engineering:
|
|
|
|
||||
|
Funded backlog
|
$
|
1,123
|
|
|
$
|
1,153
|
|
|
Negotiated unfunded backlog
|
728
|
|
|
694
|
|
||
|
Total Health and Engineering backlog
|
$
|
1,851
|
|
|
$
|
1,847
|
|
|
Total:
|
|
|
|
|
|
||
|
Funded backlog
|
$
|
3,109
|
|
|
$
|
3,007
|
|
|
Negotiated unfunded backlog
|
5,733
|
|
|
6,298
|
|
||
|
Total backlog
|
$
|
8,842
|
|
|
$
|
9,305
|
|
|
|
|
|
|
|
Three Months Ended
|
||||
|
|
May 2, 2014
|
|
May 3, 2013
|
||
|
Cost-reimbursement
|
48
|
%
|
|
46
|
%
|
|
Time and materials (T&M) and fixed-price-level-of-effort (FP-LOE)
|
28
|
|
|
26
|
|
|
Firm-fixed price (FFP)
|
24
|
|
|
28
|
|
|
Total
|
100
|
%
|
|
100
|
%
|
|
|
Three Months Ended
|
||||||||
|
|
May 2, 2014
|
|
Percent change
|
|
May 3, 2013
|
||||
|
|
(dollars in millions)
|
||||||||
|
Labor-related revenues
|
$
|
816
|
|
|
(17)%
|
|
$
|
988
|
|
|
As a percentage of revenues
|
62
|
%
|
|
|
|
62
|
%
|
||
|
M&S revenues
|
504
|
|
|
(17)%
|
|
609
|
|
||
|
As a percentage of revenues
|
38
|
%
|
|
|
|
38
|
%
|
||
|
|
|
|
|
|
Three Months Ended
|
|||||||||||||
|
|
May 2, 2014
|
|
Dollar change
|
|
Percent change
|
|
May 3, 2013
|
|||||||
|
|
(dollars in millions)
|
|||||||||||||
|
Revenues
|
$
|
1,320
|
|
|
$
|
(277
|
)
|
|
(17
|
)%
|
|
$
|
1,597
|
|
|
Cost of revenues
|
1,147
|
|
|
(230
|
)
|
|
(17
|
)%
|
|
1,377
|
|
|||
|
Selling, general and administrative expenses:
|
|
|
|
|
|
|
|
|
|
|||||
|
General and administrative
|
54
|
|
|
(44
|
)
|
|
(45
|
)%
|
|
98
|
|
|||
|
Bid and proposal
|
19
|
|
|
(1
|
)
|
|
(5
|
)%
|
|
20
|
|
|||
|
Internal research and development
|
10
|
|
|
—
|
|
|
—
|
%
|
|
10
|
|
|||
|
Intangible asset impairment charges
|
—
|
|
|
(2
|
)
|
|
(100
|
)%
|
|
2
|
|
|||
|
Separation transaction and restructuring expenses
|
1
|
|
|
(13
|
)
|
|
(93
|
)%
|
|
14
|
|
|||
|
Operating income
|
89
|
|
|
13
|
|
|
17
|
%
|
|
76
|
|
|||
|
Operating income margin
|
6.7
|
%
|
|
|
|
|
|
4.8
|
%
|
|||||
|
Non-operating expense, net
|
(18
|
)
|
|
(3
|
)
|
|
20
|
%
|
|
(15
|
)
|
|||
|
Income from continuing operations before income taxes
|
71
|
|
|
10
|
|
|
16
|
%
|
|
61
|
|
|||
|
Income tax provision
|
(25
|
)
|
|
(4
|
)
|
|
19
|
%
|
|
(21
|
)
|
|||
|
Income from continuing operations
|
46
|
|
|
6
|
|
|
15
|
%
|
|
40
|
|
|||
|
(Loss) income from discontinued operations, net of tax
|
(9
|
)
|
|
(50
|
)
|
|
(122
|
)%
|
|
41
|
|
|||
|
Net income
|
$
|
37
|
|
|
$
|
(44
|
)
|
|
(54
|
)%
|
|
$
|
81
|
|
|
|
|
|
|
|
Three Months Ended
|
|||||||||
|
National Security Solutions
|
May 2, 2014
|
|
Percent change
|
|
May 3, 2013
|
|||||
|
|
(dollars in millions)
|
|||||||||
|
Revenues
|
$
|
944
|
|
|
(12
|
)%
|
|
$
|
1,077
|
|
|
Operating income
|
77
|
|
|
8
|
%
|
|
71
|
|
||
|
Operating income margin
|
8
|
%
|
|
|
|
7
|
%
|
|||
|
|
Three Months Ended
|
|||||||||
|
Health and Engineering
|
May 2, 2014
|
|
Percent change
|
|
May 3, 2013
|
|||||
|
|
(dollars in millions)
|
|||||||||
|
Revenues
|
$
|
380
|
|
|
(27
|
)%
|
|
$
|
521
|
|
|
Operating income
|
25
|
|
|
(29
|
)%
|
|
35
|
|
||
|
Operating income margin
|
7
|
%
|
|
|
|
7
|
%
|
|||
|
|
|
|
|
|
Three Months Ended
|
||||||
|
Corporate and Other
|
May 2, 2014
|
|
May 3, 2013
|
||||
|
|
(in millions)
|
||||||
|
Operating loss
|
$
|
(13
|
)
|
|
$
|
(30
|
)
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
May 2, 2014
|
|
May 3, 2013
|
||||
|
|
(in millions)
|
||||||
|
Cash used in operating activities of continuing operations
|
$
|
(8
|
)
|
|
$
|
(102
|
)
|
|
Cash (used in) provided by investing activities of continuing operations
|
(10
|
)
|
|
9
|
|
||
|
Cash used in financing activities of continuing operations
|
(233
|
)
|
|
(53
|
)
|
||
|
Cash provided by (used in) operating activities of discontinued operations
|
4
|
|
|
(26
|
)
|
||
|
Cash used in investing activities of discontinued operations
|
—
|
|
|
(1
|
)
|
||
|
Total decrease in cash and cash equivalents
|
$
|
(247
|
)
|
|
$
|
(173
|
)
|
|
|
|
|
|
|
Stated interest rate
|
|
Effective interest rate
|
|
May 2,
2014 |
|
January 31, 2014
|
||||||
|
|
(dollars in millions)
|
||||||||||||
|
Leidos Holdings, Inc. senior unsecured notes:
|
|
|
|
|
|
|
|
||||||
|
$450 million notes, which mature in December 2020
|
4.45
|
%
|
|
4.53
|
%
|
|
$
|
449
|
|
|
$
|
449
|
|
|
$300 million notes, which mature in December 2040
|
5.95
|
%
|
|
6.03
|
%
|
|
300
|
|
|
300
|
|
||
|
Leidos, Inc. senior unsecured notes:
|
|
|
|
|
|
|
|
|
|
||||
|
$250 million notes, which mature in July 2032
|
7.13
|
%
|
|
7.43
|
%
|
|
248
|
|
|
248
|
|
||
|
$300 million notes, which mature in July 2033
|
5.50
|
%
|
|
5.78
|
%
|
|
296
|
|
|
296
|
|
||
|
Capital leases and other notes payable due on various dates through fiscal 2021
|
0%-3.7%
|
|
|
Various
|
|
40
|
|
|
40
|
|
|||
|
Total notes payable and long-term debt
|
|
|
|
|
$
|
1,333
|
|
|
$
|
1,333
|
|
||
|
Less current portion
|
|
|
|
|
3
|
|
|
2
|
|
||||
|
Total notes payable and long-term debt, net of current portion
|
|
|
|
|
$
|
1,330
|
|
|
$
|
1,331
|
|
||
|
Fair value of notes payable and long-term debt
|
|
|
|
|
$
|
1,358
|
|
|
$
|
1,350
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c)
|
Purchases of Equity Securities by the Company
|
|
Period
|
(a)
Total Number of Shares (or Units) Purchased (1) |
|
(b)
Average Price Paid per Share (or Unit) |
|
(c)
Total Number of Shares (or Units) Purchased as Part of Publicly Announced Repurchase Plans or Programs (2) |
|
(d)
Maximum Number (or Approximate Dollar Value) of Shares (or Units)that May Yet Be Purchased Under the Plans or Programs (2) |
|||||
|
February 1, 2014 - February 28, 2014
(3)
|
982,621
|
|
|
$
|
45.84
|
|
|
981,391
|
|
|
13,455,326
|
|
|
March 1, 2014 - March 31, 2014
|
31,150
|
|
|
45.21
|
|
|
—
|
|
|
13,455,326
|
|
|
|
April 1, 2014 - April 30, 2014
(4)
|
4,620,599
|
|
|
35.63
|
|
|
4,495,220
|
|
|
8,960,106
|
|
|
|
May 1, 2014 - May 2, 2014
|
—
|
|
|
—
|
|
|
—
|
|
|
8,960,106
|
|
|
|
Total
|
5,634,370
|
|
|
$
|
37.47
|
|
|
5,476,611
|
|
|
|
|
|
(1)
|
The total number of shares purchased includes: (i) shares of common stock purchased under the terms of the accelerated share repurchase agreements; (ii) shares surrendered to satisfy statutory tax withholdings obligations related to vesting of restricted stock awards; and (iii) shares surrendered in payment of the exercise price of non-qualified stock options and/or to satisfy statutory tax withholdings obligations.
|
|
(2)
|
We may repurchase up to 20 million shares of Leidos common stock under the 2013 Stock Repurchase Program, which was publicly announced in December 2013.
|
|
(3)
|
In December 2013, we entered into an Accelerated Share Repurchase ("ASR") agreement with a financial institution, whereby we paid an aggregate of $300 million and received a total of 6.5 million shares of Leidos outstanding shares of common stock with 5.6 million of those shares delivered in the fourth quarter of fiscal 2014 . The final delivery of the remaining approximately 1.0 million shares under this program was completed in February 2014. All shares delivered were immediately retired.
|
|
(4)
|
In March 2014, we entered into a second ASR agreement with a different financial institution, whereby we paid an aggregate of $200 million and received approximately 4.5 million shares of Leidos outstanding shares of common stock during April 2014, or approximately 80% of the expected number of shares to be repurchased under the ASR. The final delivery of the remaining shares under this program is expected to be completed during the second quarter of fiscal 2015. All shares delivered were immediately retired.
|
|
|
|
|
|
Exhibit
Number |
Description of Exhibit
|
|
|
|
|
|
|
|
10.1
|
Form of Restricted Stock Unit Award Agreement (adopted March 2014) of Leidos Holdings, Inc.'s 2006 Equity Incentive Plan.
|
|
|
|
|
10.2
|
Form of Restricted Stock Unit Award Agreement (Non-Employee Directors) (adopted March 2014) of Leidos Holdings, Inc. 2006 Equity Incentive Plan.
|
|
|
|
|
10.3
|
Form of Restricted Unit Award Agreement (Management) (adopted March 2014) of Leidos Holdings, Inc.’s 2006 Equity Incentive Plan.
|
|
|
|
|
10.4
|
Form of Performance Share Award Agreement (adopted April 2014) of Leidos Holdings, Inc.'s 2006 Equity Incentive Plan.
|
|
|
|
|
10.5
|
Memorandum of Understanding, executed on March 24, 2014, between the Company and K. Stuart Shea.
|
|
|
|
|
31.1
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
31.2
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
32.1
|
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
32.2
|
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
101
|
Interactive Data File.
|
|
|
|
|
|
Leidos Holdings, Inc.
|
|
|
|
/s/ Mark W. Sopp
|
|
Mark W. Sopp
Executive Vice President and Chief Financial Officer and
as a duly authorized officer
|
|
Leidos, Inc.
|
|
|
|
/s/ Mark W. Sopp
|
|
Mark W. Sopp
Executive Vice President and Chief Financial Officer and
as a duly authorized officer
|
|
|
|
|
|
Exhibit
Number |
Description of Exhibit
|
|
|
|
|
|
|
|
10.1
|
Form of Restricted Stock Unit Award Agreement (adopted March 2014) of Leidos Holdings, Inc.'s 2006 Equity Incentive Plan.
|
|
|
|
|
10.2
|
Form of Restricted Stock Unit Award Agreement (Non-Employee Directors) (adopted March 2014) of Leidos Holdings, Inc. 2006 Equity Incentive Plan.
|
|
|
|
|
10.3
|
Form of Restricted Unit Award Agreement (Management) (adopted March 2014) of Leidos Holdings, Inc.’s 2006 Equity Incentive Plan.
|
|
|
|
|
10.4
|
Form of Performance Share Award Agreement (adopted April 2014) of Leidos Holdings, Inc.'s 2006 Equity Incentive Plan.
|
|
|
|
|
10.5
|
Memorandum of Understanding, executed on March 24, 2014, between the Company and K. Stuart Shea.
|
|
|
|
|
31.1
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
31.2
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
32.1
|
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
32.2
|
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
101
|
Interactive Data File.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|